These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1561667)

  • 21. The use of the dilute Russell viper venom time for the diagnosis of lupus anticoagulants.
    Thiagarajan P; Pengo V; Shapiro SS
    Blood; 1986 Oct; 68(4):869-74. PubMed ID: 3092888
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Some recent developments with lupus anticoagulants.
    Exner T
    Blood Coagul Fibrinolysis; 1994 Apr; 5(2):281-9. PubMed ID: 8054462
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Evaluation of sensitivity and specificity of confirmatory assays for lupus anticoagulant (LA) detection].
    Imoto K; Yasumuro Y; Taki M; Suzuki Y; Akatu S; Tajima C; Ichikawa Y
    Rinsho Byori; 1996 Aug; 44(8):797-801. PubMed ID: 8816068
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The dilute Russell's viper venom time.
    Radhakrishnan K
    Methods Mol Biol; 2013; 992():341-8. PubMed ID: 23546726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A new-generation dilute Russell's viper venom time assay system for lupus anticoagulants: evaluation of detection utilising frozen reagents and controls.
    Moore GW; Tugnait S; Savidge GF
    Br J Biomed Sci; 2005; 62(3):127-32. PubMed ID: 16196459
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Taipan snake venom time: a new test for lupus anticoagulant.
    Rooney AM; McNally T; Mackie IJ; Machin SJ
    J Clin Pathol; 1994 Jun; 47(6):497-501. PubMed ID: 8063928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The dilution effect of equal volume mixing studies compromises confirmation of inhibition by lupus anticoagulants even when mixture specific reference ranges are applied.
    Moore GW; Savidge GF
    Thromb Res; 2006; 118(4):523-8. PubMed ID: 16263154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lupus anticoagulants and thrombosis: clinical association of different coagulation and immunologic tests.
    Galli M; Dlott J; Norbis F; Ruggeri L; Cler L; Triplett DA; Barbui T
    Thromb Haemost; 2000 Dec; 84(6):1012-6. PubMed ID: 11154107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An evaluation of two commercial test procedures for the detection of lupus anticoagulant.
    Schjetlein R; Wisløff F
    Am J Clin Pathol; 1995 Jan; 103(1):108-11. PubMed ID: 7817935
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lupus Anticoagulant Testing: Taipan Snake Venom Time with Ecarin Time as Confirmatory Test.
    Moore GW
    Methods Mol Biol; 2023; 2663():263-274. PubMed ID: 37204716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Lupus anticoagulant screening: comparison of 5 tests (author's transl)].
    Follea G; Ffrench P; Trzeciak MC; Dechavanne M
    Nouv Rev Fr Hematol (1978); 1981; 23(4):203-7. PubMed ID: 7312614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alteration in the laboratory profile of a lupus anticoagulant in a patient with non-Hodgkin's lymphoma.
    Moore GW; Kamat AV; Gurney DA; O'Connor O; Rangarajan S; Carr R; Savidge GF
    Clin Lab Haematol; 2004 Dec; 26(6):429-34. PubMed ID: 15596003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Are laboratories following published recommendations for lupus anticoagulant testing? An international evaluation of practices.
    Moffat KA; Ledford-Kraemer MR; Plumhoff EA; McKay H; Nichols WL; Meijer P; Hayward CP
    Thromb Haemost; 2009 Jan; 101(1):178-84. PubMed ID: 19132206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative Risk for Single-Positive Lupus Anticoagulant Results With Different Anticoagulants.
    Khan W; Tormey CA; Rinder HM; Siddon AJ
    Am J Clin Pathol; 2023 May; 159(5):417-419. PubMed ID: 36940149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinant thromboplastin inhibition assay for the detection of lupus anticoagulant.
    Zanon E; Saracino MA; Simioni P; Scarano L; Girolami B; Girolami A
    Clin Lab Haematol; 1995 Sep; 17(3):231-5. PubMed ID: 8719896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of lupus like anticoagulant: current laboratory practice in the United Kingdom. The Lupus Anticoagulant Working Party.
    J Clin Pathol; 1990 Jan; 43(1):73-5. PubMed ID: 2107213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Similar mechanism of various lupus anticoagulants.
    Exner T
    Thromb Haemost; 1985 Feb; 53(1):15-8. PubMed ID: 3922078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recommendations for appropriate activated partial thromboplastin time reagent selection and utilization.
    Fritsma GA; Dembitzer FR; Randhawa A; Marques MB; Van Cott EM; Adcock-Funk D; Peerschke EI
    Am J Clin Pathol; 2012 Jun; 137(6):904-8. PubMed ID: 22586049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of phospholipid on the detection of lupus anticoagulants by the dilute Russell viper venom time.
    Brandt JT; Triplett DA
    Arch Pathol Lab Med; 1989 Dec; 113(12):1376-8. PubMed ID: 2511818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Further evidence of false negative screening for lupus anticoagulants.
    Moore GW; Henley A; Greenwood CK; Rangarajan S
    Thromb Res; 2008; 121(4):477-84. PubMed ID: 17602725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.